Clinical trial
Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone…
NCT00262314 · EMD Serono, Industry · Completed
Key facts
| NCT number | NCT00262314 |
|---|---|
| Title | Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients |
| Official title | Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients |
| Acronym | RENEW |
| Lead sponsor | EMD Serono, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 509 |
| Start date | Oct 1, 2000 |
| Primary completion | Jan 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Dec 6, 2005 |
| Last update posted | Nov 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: